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 ABSTRACT                                                                                                                                            
Inborn errors of metabolism revealed by organic acid 
profile analysis in high risk Egyptian patients: Six 
years experience
Ekram Fateen1 and Amr Gouda1, H. Boehles2 and A. Sewell2
1Biochemical Genetics Department, National Research Centre, Cairo,  Egypt. 
2Children Hospital, Johann Wolfgang Goethe University, Frankfurt, Germany.
Objective: To determine the prevalence and types of inborn errors of amino 
acid or organic acid metabolism in a group of high risk Egyptian children with 
clinical signs and symptoms suggestive of inherited metabolic diseases.
Subjects and Methods: 117 (79 males ═ 67.5 % and 38 females ═ 32.5 %) 
high risk patients with signs and symptoms of a metabolic disorder were stud-
ied, their ages ranged from 3 days to 12 years.
Analysis of urine organic acids by gas chromatography/mass spectrometry 
(GC/MS) was performed to all patients.
Results: 22(18.8 % of the total) cases were diagnosed with different types of 
aminoacidopathies or organic acidurias. The disease profile showed increased 
lactate in 12 cases (54 %), glutaric aciduria type I 3cases (13 %), phenylketon-
uria 2 cases (9 %), maple syrup urine disease 1 case (4.5 %), glutaric aciduria 
type II 1 case (4.5 %), methylmalonic aciduria 1 case (4.5 %), Canavan disease 
1 case (4.5 %) and non ketotic hyperglycemia 1 case (4.5 %). 
Conclusion: The results demonstrate the importance of the organic acid profile 
in the diagnosis of high risk patients. The diagnosed organic acid pattern in this 
study showed that 10.2 % of the patients had a mitochondrial energy defect.






etry, organic acid profile analysis.
INTRODUCTION                                         
The term “organic acidemia” or “organ-
ic aciduria” applies to a diverse group 
of disorders characterized by the excre-
tion of non-amino organic acids in urine. 
The organic acidemias share many clini-
cal similarities. Most organic acidemias 
result from deficiencies of specific en-
zymes in the breakdown pathways of 
amino acids or from enzyme deficiencies 
in beta oxidation of fatty acids or carbo-
hydrate metabolism. Organic acids also 
are found in the urine of some patients 
with mitochondrial disease. The patho-
physiology results from accumulation of 
precursors and deficiency of products of 
that affected pathway. The accumulated 
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precursors are themselves toxic or me-
tabolized to produce toxic compounds.1
Inherited disorders of organic acid 
metabolism have a high cumulative 
frequency, and despite heterogeneous 
etiology and varying clinical presenta-
tion, the manifestation of neurological 
disease is common. It has been demon-
strated for some of these diseases that 
accumulating pathological metabolites 
are directly involved in the manifesta-
tion of neurological disease. Various 
pathomechanisms have been suggested 
in different models in vitro and in vivo 
including an impairment of brain ener-
gy metabolism, an imbalance of excit-
atory and inhibitory neurotransmission, 
altered transport across the blood-brain 
barrier and between glial cells and neu-
rons, impairment of myelination and 
disturbed neuronal efflux of metabolic 
water.2
Many of the organic aciduria responds 
to treatment, especially in the neonatal 
period, they demand urgent diagnosis 
and management. The aim of therapy is 
to restore biochemical and physiologi-
cal homeostasis. The treatments, while 
similar in principle, depend on the spe-
cific biochemical lesion and are based 
on the position of the metabolic block 
and the effects of toxic compounds. 
Treatment strategies include:
1. Dietary restriction of the accumu-
lated precursor.
2. Use of adjunctive compounds to 
dispose toxic metabolites.
3. Use of adjunctive compounds to 
increase activity of deficient en-
zymes.
Despite appropriate management, pa-
tients with organic aciduria have a 
greater risk of infection and a higher 
incidence of pancreatitis, which can be 
fatal.3
Clinical and laboratory findings that 
should suggest an organic aciduria in-
clude acidosis, ketosis, hyperammone-
mia, abnormal liver function tests, hy-
poglycemia and neutropenia.4
SUBJECTS AND METHODS                      
Subjects:
Random urine samples were collected 
from 117 Egyptian children referred to 
our lab (Biochemical Genetics) from 
different hospitals and clinics with sus-
picion of an inborn error of metabolism 
from 2002-2008.
Blood samples were also obtained and 
the plasma immediately separated.
Methods:
All samples were screened by the fol-
lowing tests: Ferric chloride test for 
phenylketones, 2- 4- dinitrophenylhy-
drazin (DNPH) test for α-ketoacids, 
nitrosonaphthol test for increased ty-
rosine and its derivatives, Benedict test 
for reducing substances, cyanide-nitro-
prusside test for sulfur containing ami-
no acids. Thin layer chromatographic 
separation of blood and urine amino 
acids was performed according to the 
method of Borden.5 
Ammonia and plasma lactate were de-
termined for some samples as requested 
by the physician. Ammonia enzymatic 
assay was detected according to the 
method of Ishihara6. Lactate was de-
tected colorimetric according to the 
method of Artuch.7
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Urine sample preparation and organ-
ic acid analysis:
Organic acid analysis was performed 
according to Sweetman8. Urine samples 
with volumes corresponding to a creati-
nine of 1mmol/L were made up to 2ml 
with distilled water acidified to PH 1.5 
and mixed with 100μl of decanoic acid 
5 mM/L, 100μl of Hepatodecanoic acid 
75 mg/200ml and 100μl of Hepatogly-
cine 299μmpl/L (internal standards). 
Solid sodium chloride was added and 
the organic acids were extracted twice 
with 2ml ethylacetate. 
The organic acids were pooled and 
evaporated under nitrogen at 37˚C in 
dry block heater. 
Derivatization was then performed with 
75μl of BSTFA (bis-trimethylsylil tri-
flouracetamide + 1 % trimethyl chlo-
rosilane) and 20μl of pyridine in a fume 
cupboard to each dried extract, the ex-
tract was heated for 30 minuets at 80˚C 
and then transferred into GC/MS vials.
The metabolites were chromatographi-
cally analyzed as trimethylsilyl (TMS) 
compounds. Half micro liter of each de-
rivatized sample was then injected into 
Helwatt Packed 5890 equipment with a 
CP-sil 8 CB capillary column. 
The GC/MS temperatures were as fol-
lows: Injector 250˚C, column 90˚C to 
280˚C with an increment of 3˚C per 
min, ion source 150˚C and mass ana-
lyzer 35˚C. The total run time was 75 
min. Finally, the mass spectrometer was 
programmed from m/z 10-650 at the 
rate of 0.6 Hz.
RESULTS                                                                      
The present study included 117 patients, 
the distribution of these patients ac-
cording to sex and age are represented 
in Tables 1 and 2, respectively.




Male (M) Female (F) M/F
117 79 (67.5 %) 38 (32.5 %) 2/1
Table 2: Age groups of the studied patients.
Age Number of patients Percentage
Group I 1-50 days 12 10.3 %
Group II 2-12 months 43 36.8 %
Group III 1-4 years 45 38.4 %
Group VI 4-12 years 17 14.5 %









3 cases were 
positive (2.61 %)
DNPH 117 (100 %)
8 cases were 
positive (6.8 %)
Benedict 117 (100 %)




117 (100 %) Negative (0 %)
Nitrosonaphthol 117 (100 %) Negative (0 %)
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Table 4: Results of TLC of Plasma and Urine.
Test Number of patients tested Positive results
Amino acids (plasma) 117 (100 %)
- 25 cases increased glutamic acid & glutamine
- 2 cases increased phenylalanine
- 1 case increased valine, leucine, isoleucine 
- 2 case increased glycine
- 13 cases increased  alanine
Amino acids (urine) 117 (100 %)
- 25 cases increased glutamic acid & glutamine
- 2 cases increased phenylalanine
- 1 case increased valine, leucine, isoleucine 
- 1 case increased glycine
Ammonia level was measured in plas-
ma of 43 cases only as well as plasma 
lactate was measured in plasma of 29 
cases.
Table 5: Plasma ammonia and lactate results.
Test Number of patients tested Positive results
Plasma Ammonia 43 (36.8 %) 25 cases (58.1 %) had high  NH3 level (>47 μmol/L)
Plasma Lactate 29 (24.8 %) 12 cases (41.4 %) had high lactate level (> 12mg/dl )
Table 6: Organic acid disorders detected in this study.
Diseases Number of patients diagnosed





Glutaric aciduria type I
Glutaric aciduria type II
Phenylketonuria (PKU)




























Table 7: Other findings in the organic acid profile.
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The 22 diagnosed cases were further 
tabulated according to age groups as 
shown in (Table 8).
Table 8: Diagnosed cases according to age groups.
Group 
                 Age
Number Diagnosed Percentage Diseases
Group I 
1-50 days 12 3 25%
PKU (1)
Glutaric aciduria type I (1)
Lactic acidemias (1)
Group II
2-12 month 43 10 23.3%
PKU (1)
Nonketotic hyperglycemia (1)
Glutaric aciduria type I (1)
Lactic acidemias (5)
MSUD (1)
Glutaric aciduria type II (1)
Group III
1-4 years 45 7
15.6% Glutaric aciduria type I (1)Lactic acidemias (5)
Canavan disease (1)
Group IV
4-12 years 17 2 11.8 %
Lactic acidemias (1)
Methylmalonic acidemia (1)
DISCUSSION                                                      
Organic acidemias or organic acidu-
rias are a group of inborn error of me-
tabolism generally caused by a severe 
deficiency of one enzyme activity of 
the amino acid, carbohydrate or lipid 
metabolism9,10 and spans a wide range 
of presentations involving multiple 
body systems with the predominance of 
the central nervous system.
Disorders of organic acid metabolism 
are currently detected by GC analysis 
of urinary organic acids. Since 1966 by 
Tanaka who was the first one to use GC 
to identify isovaleric acidemia.11
Many reports have shown that organic 
acidemias are relatively common disor-
ders among the inherited errors of me-
tabolism. 12-16
Organic acidemias are frequent inherit-
ed metabolic disorders among severely-
ill children and constitute, together with 
aminoacidopathies, the most prevalent 
group of inborn errors of metabolism in 
high-risk patients.17
It is therefore essential to detect the af-
fected children early in order to institute 
treatment that is available for some of 
these disorders. The diagnosis of these 
disturbances requires identification of 
the abnormal patterns of organic acids 
in biological fluids, especially urine by 
gas chromatography coupled to mass 
spectrometry.8
The present study is an extended and 
complete study for the diagnosis of 
primary disorders of organic acid me-
tabolism in high-risk Egyptian patients 
using GC/MS. 117 patients with suspi-
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cion of inherited error of metabolism 
especially organic acidemias had their 
urine specimen analyzed for organic ac-
ids pattern.
Blood and urine specimens from these 
patients were also screened for the de-
tection of other inborn errors of me-
tabolism. Plasma ammonia and lactate 
were determined for some of them as 
requested by the pediatrician; although 
plasma NH3 and lactate should be de-
termined to all high risk children at the 
time of obtaining the urine for the or-
ganic acids analysis. 
The present study included 79 males 
(67.5 %) and 38 females (32.5 %) 
(Table 1). Their age ranged from 2 days 
to 12 years (Table 8). Although organic 
acids are mostly inherited autosomal 
recessive disorder; the male predomi-
nance reflects the importance of males 
to our population like most eastern com-
munities18. This male predominance is 
observed in other studies in our popula-
tion done to diagnose other metabolic 
disorders. All these previous studies 
showed male predominance inspite of 
the autosomal recessive mode of inheri-
tance of the investigated disorders. 
The patients were divided into 4 age 
groups (Table 2). Group I from 1-50 
days included 12 patients (10.3 %), 
Group II from 2-12 months included 
43 patients (36.8 %), Group III from 
1-4 years included 45 patients (38.4 %) 
and Group IV from 4-12 years included 
17 patients (14.5 %). The significant 
differences in the concentrations of 
the metabolites between different age 
groups show the necessity of using age 
related reference ranges for the diag-
nosis of metabolic diseases19. Most of 
organic acidemias present early in life, 
still Group III (age 1-4 years) was the 
largest one. But according to table (8) 
the diagnosed cases within this group 
represented 15.6 % only, while 25 % 
of Group I was diseased. Group I (age 
1-50 days) represent the vulnerable age 
and unfortunately most of them die from 
acute life threatening crises very early 
without being diagnosed. This might 
be the cause that this group constituted 
only 10.3 % of total studied cases.
This situation shows the importance of 
early screening of this group by urine 
analysis of organic acids profile. These 
cases are mostly misdiagnosed with 
infectious diseases or remain undiag-
nosed due to lack of awareness by the 
physician by the metabolic disorders. 
As seen from our study Group II and 
Group III comprise 36.8 % and 38.4 
% of the cases, respectively. These age 
groups are relatively high for the diag-
nosis of organic aciduria. This could be 
tentatively attributed to lack of aware-
ness of these genetic diseases by the 
Egyptian physicians especially in the 
villages together with the lack of their 
awareness with the presence of a meta-
bolic lab in Cairo- Egypt for diagnosis 
of such cases. This leads to the high 
mortality of patients affected by these 
diseases without being diagnosed. His-
tory taking and the presence of a previ-
ously affected child in a consanguine-
ous marriage should draw the attention 
of the physician to a metabolic disease. 
The chemical tests and qualitative ami-
no acids chromatography were done to 
all patients (Tables 3&4, respectively). 
3 cases had positive ferric chloride test 
(2.61 %), 8 cases had positive DNPH 
(6.8 %) and plasma and urine thin lay-
er chromatography showed increased 
phenylalanine in plasma and urine of 
two patients diagnosed as PKU and in-
creased branched chain amino acids in 
192
Organic acid profile analysis in high risk Egyptian Patients
plasma and urine of one patient, diag-
nosed as MSUD.
Synchronously the organic acid profile 
was analyzed and confirmed the diag-
nosis of Phenylketonuria and MSUD in 
these patients. This proves that simple 
tests are still very helpful to diagnose 
some diseases without the need of more 
sophisticated techniques, which need 
more time, skills and are costier. In our 
lab and in many other labs around the 
world; these tests are still used as a first 
screening strategy before using a higher 
one. Organic acid analysis is expensive 
and this is the setback especially for 
developing countries with limited re-
sources for diagnosing rare disorders. 
Thin layer chromatographic separation 
of amino acids showed increased glu-
tamic acid and glutamine in the urine 
and plasma of 25 patients (Table 4). 
This is secondary to the high plasma 
NH3 not tolerated by these cases. Plas-
ma NH3 levels were measured to 43 
cases (36.8 %) (Table 5) according to 
the pediatrician request. 25 cases had 
high NH3 level (58.1 %). High plasma 
NH3 level is recorded in many meta-
bolic disorders and must be determined 
early with the first screening tests to in-
stitute treatment before any brain dam-
age is caused by the high NH3 levels 
not tolerated by the patients as seen by 
the increased glutamic acid and gluta-
mine in the plasma and urine of them. 
The abnormal laboratory findings in 
cases with organic aciduria beside the 
hyperammonemia are metabolic aci-
dosis, hypoglycemia, ketosis/ketonuria 
and pancytopenia.
Plasma lactate was measured for 29 cas-
es according to the pediatrician request 
and 12 cases showed high plasma lac-
tate levels (41.4 %) (Table 5). Primary 
lactic acidemia was the most frequent 
disorder diagnosed among the Brazilian 
patients in a study done on 234 cases in 
a study like ours on high-risk children16. 
Further more, despite the absence of 
suspicion by referral physician, the 
presence of ketolactic acidosis with or 
without hyperammonemia is an indica-
tion for organic acid analysis. Accumu-
lation of lactic acid is found in various 
disorders especially those with energy 
defects i.e. mitochondrial disorders in-
cluding fatty acids oxidation defects. 
Out of the 117 samples analyzed 
for organic acid profile, 22 patients 
(18.8 %) showed abnormal urinary 
excretion of organic acids. The most 
frequently diagnosed disorders in this 
high-risk group (Table 6), were lactic 
acidemia 12 cases (10.2 %) of the total 
cases and 54 % of the diagnosed cases. 
Primary lactic academia presented 
54 % of the diagnosed cases, reflect-
ing that over 50 % of the high-risk 
diagnosed patients have an energy de-
fect; which needs further enzymatic 
and molecular studies to reach a final 
diagnosis. No MCAD deficiency was 
diagnosed among them; although in a 
previous study by the same group of re-
searchers who found 82 % MCAD de-
ficiency among high-risk patients with 
nonketotic hypoglycemic attacks15. 
This is attributed to the selection crite-
ria of that study which is totally differ-
ent from this one. 
The second frequent diagnosed disease 
in this study is glutaric aciduria type I 
presenting 13.6 % of the abnormal or-
ganic acid profile detected. This is a 
surprisingly high frequency of the dis-
order, which can not reflect its frequen-
cy among our population. Two patients 
were diagnosed in the second and the 
third age groups when the macrocepha-
193
Fateen et al.
lly was very obvious. The third case 
was diagnosed relatively early in group 
I because he was a brother of one of the 
already diagnosed patients. 
A larger study of the Egyptian popula-
tion must be done to find out the real 
prevalence of this disorder. 
In the age Group I (1-50 days) 3 cases 
from 12 (25 %) were diseased, in the 
age group II (2-12 months) 10 cases 
from 43 (23.3 %) were diagnosed, in 
the age Group III (1-4 years) only 7 cas-
es from 45 (15.6 %) were also diseased 
and in the age Group IV (4-12 years) 2 
cases from 17 (11.8 %) were diagnosed. 
The highest frequency was found in the 
age group I (1-50 days) 25 %. Still this 
group is undiagnosed due to several 
factors discussed before like the high 
mortality rate among this Group of dis-
orders if not diagnosed and treated very 
early in life. Add to this factor the lack 
of awareness of such genetic disorders 
among the physicians in Egypt. 
Two cases of phenylketonuria (9 % of 
diagnosed cases) were diagnosed in age 
Group I and II this is due to the lack of 
neonatal screening program for PKU in 
Egypt. The two cases were diagnosed 
by positive FeCl3 and positive DNPH 
tests (Table 3) and the presence of 
phenylalanine bands in the TLC (Thin 
Layer Chromatography) of their plasma 
and urine. Organic acid profile con-
firmed the diagnosis.
This draws the attention to the impor-
tance of adding PKU to the existing na-
tional neonatal screening program for 
TSH. Our findings also show the impor-
tance of simple tests in diagnosing this 
disorder without delay and performing 
higher technical and more expensive 
tests. 
One case of MSUD (4.5 %) was also 
diagnosed by positive FeCl3 and posi-
tive DNPH tests with the presence of 
a branched chain amino acids band in 
the TLC of plasma and urine of the af-
fected patient. The organic acid profile 
confirmed the diagnosis by the presence 
of the 2OH isovaleric peak. MSUD can 
be simply diagnosed by the screening 
chemical tests and TLC; which can be 
life saving to such cases during crisis.
A case of nonketotic hyperglycemia 
was also detected by the presence of 
excessive glycine band in the TLC and 
negative DNPH test. The diagnosis was 
also confirmed by abnormal organic 
acid profile.
Both cases of MSUD and nonketotic 
hyperglycemia were diagnosed in age 
group II (2-12 month), which is not too 
late for MSUD. Regarding nonketotic 
hyperglycemia, it is usually an aggres-
sive disorder leading to acute encephal-
opathy in most of the affected neonates. 
Although it can be simply diagnosed 
early by TLC of the patients plasma and 
urine20 without the presence of ketone 
bodies unlike the excretion of glycine 
observed with cases of organic acidu-
ria, where ketosis is a main laboratory 
finding.
Our results regarding these 4 cases 
(18.1%) diagnosed with aminoacidopa-
thies plus the 5 cases (22 %) diagnosed 
with primary organic acid disorders 
(both 40.1%) coincide with the results 
of the Brazilian experience21. Both stud-
ies agree that organic acids are frequent 
inherited disorders among severely ill 
children and constitute, together with 
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the aminoacidopathies, the most preva-
lent group of in born error of metabo-
lism in high-risk populations. Symp-
toms are usually severe and the out-
come is often bad. Once they become 
symptomatic, leading to a considerable 
number of patients to death. Those who 
survive present a variable degree of 
physical and/or mental disability. Early 
detection and treatment are essential to 
save and for better outcome of these 
patients. Abnormal patterns of organic 
acids in the biological fluids especially 
urine, provide a diagnostic clue to IEM 
including amino acids disorders, urea 
cycle, disorders of carbohydrate me-
tabolism and mitochondrial fatty acid 
oxidation defects.
The organic acid profile also showed 
increased excretion of Hippuric acid in 
4 cases. Hippuric acid is the end metab-
olite of Na-benzoate used in the treat-
ment of increased NH3 levels in these 
high-risk children. 
This shows the importance of NH3 
monitoring and the adjustment of the 
Na-benzoate dose accordingly. 7 cases 
showed increased excretion of Val-
proates. Valproates are a group of an-
tiepileptic drugs, which should not be 
given to neonates with metabolic dis-
orders as they aggravate the condition. 
This shows the lack of awareness about 
the management of metabolic disorders 
by many physicians. Valproates should 
not be prescribed by them to any condi-
tion with suspicion of a metabolic dis-
order.
Methylmalonic acidemia (MMA) is 
the most common organic acidemia in 
many studies13,24. In our study only one 
case with MMA was diagnosed; repre-
senting 4.5 % of the 22 abnormal organ-
ic acid profiles. If we say that this dis-
order is equal to 4.5 % of the abnormal 
pattern, this is more acceptable. Strange 
enough it was diagnosed in age group 
IV (4-12 years).
This is most probably a vitamin B12 re-
sponsive case of MMA, diagnosed late 
due to the abundance of vitamin B12 in 
the food of many Egyptians due to our 
nutritional habits. 
Still a larger study is needed to know 
the real prevalence of MMA in our pop-
ulation, bearing in mind that the study 
represents the high-risk patients only 
and not a mass screening one. 
Fifteen years experiment selective 
screening for organic acids in Brazil 
on the other hand diagnosed 34 cases 
with MMA from 866 Brazilian children 
representing 0.49 % but 14.5 % of the 
234 abnormal organic acids diagnosed 
in their study. This incidence among the 
diagnosed cases is 10 % higher than our 
findings. 
Of course their diagnosed cases were 
also ten times our 22 positive. Also, 
Brazil is a totally different population 
in origin.16
One case with glutaric aciduria type II 
was also diagnosed in age group II. It 
also represents 4.5 % of the diagnosed 
cases. The Brazilian study diagnosed 8 
cases of glutaric aciduria type II pre-
senting 3.4 % of their diagnosed cases. 
These rare disorders need very large 
studies to find out their frequency in a 
certain population. 
Glutaric aciduria type II is due to de-
ficient electron transfer from the FAD-
dependant dehydrogenases to the respi-
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ratory chain due to genetic defects of 
the electron transfer flavoprotein (ETF) 
or ETF-coenzyme Q oxidoreductase 
(ETF-QO). Neonatal presentation is 
usually fatal in the first weeks of life. 
This case was diagnosed in age group 
II. The case was well managed till the 
age of four years, when she died during 
an acute crisis. 
One case of Canavan disease was diag-
nosed in group III (age 1-4 years). This 
is the age when the full clinical picture 
of the disease becomes obvious with 
macrocephally, leukodystrophy and op-
tic atrophy. The high peak of N-acety-
laspartic acid in the organic acid profile 
was characteristic of the disorder. This 
abnormality presented 4.5 % of the ab-
normal organic acid profiles detected in 
this study.
In a previous study in Egypt of 50 high 
risk Egyptian children by El Gammal27, 
25 cases (50%) were found to have 
different amino acid and organic acid 
disorders excluding phenylketonuria. 
Fourteen cases had organic acidemias 
and 4 cases had amino acid disorders.   
CONCLUSION                                                 
The organic acid profile detection by 
GC/MS is a key to the diagnosis of 
many metabolic disorders. This needs 
a lot of experience and training by ex-
perts like our coauthors Prof. Dr. Boe-
hles and Prof. Dr. Sewell.
This technology must be available in 
developing countries, with high con-
sanguinity rates, to help in the early 
diagnosis and treatment of such cases. 
Still simple screening tests can help in 
the diagnosis of some of these disorders 
especially aminoacidopathies. 
Also, the measuring of NH3 and lactate 
levels and early management of both 
items till a final diagnosis is reached; 
can rescue many newborns and prevent 
many of the undesired sequalae of these 
disorders.
Finally, a larger epidemiological study 
is needed to find out the frequency of 
each of the diagnosed disorders among 
our population. Because of the high rate 
of consanguineous marriages which 
leads to a high prevalence of autosomal 
recessive inherited disorders, with the 
use of new laboratory techniques, we 
expect a high frequency of inherited 
metabolic diseases in our country.
Recommendation: A larger study is 
recommended to determine the preva-
lence of the different inborn errors of 
metabolism among our patients.
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